A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells - PubMed (original) (raw)

A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells

J H Kabarowski et al. EMBO J. 1994.

Abstract

The Philadelphia translocation commonly observed in chronic myeloid leukaemia (CML) and a proportion of cases of acute leukaemia results in the creation of a chimeric fusion protein, BCR-ABL. The fusion protein exhibits an elevated tyrosine kinase activity as compared to normal ABL. Using a temperature sensitive mutant of p210 BCR-ABL (ts-p210) we find that the primary effect of BCR-ABL expression in an IL-3 dependent cell line is to prolong survival following growth factor withdrawal; only a small proportion of cells remain viable and rapidly evolve to complete growth factor independence. During passage in the presence of IL-3 at the temperature permissive for kinase activity, ts-p210 expressing cultures become dominated by completely growth factor independent cells within 10-30 days. There is also a significant difference between BCR-ABL and IL-3 mediated signalling with respect to the MAP kinase pathway; in contrast to IL-3 stimulation or v-ABL expression, BCR-ABL does not signal ERK 2 (MAP 2 kinase) activation, underlining the apparent inability of BCR-ABL to deliver an immediate proliferative signal in Ba/F3 cells. Our data suggest that growth factor independence does not simply reflect the convergence of BCR-ABL and IL-3 mediated signalling pathways and its development, at least in Ba/F3 cells, requires prolonged exposure to BCR-ABL kinase activity. We suggest that the myeloid expansion characteristic of CML may result from the prolongation of survival of myeloid progenitor cells under conditions of limiting growth factor rather than their uncontrolled proliferation.

PubMed Disclaimer

Cited by

The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and -independent pathways: roles for phosphatidylinositol 3-kinase and Raf.
Neshat MS, Raitano AB, Wang HG, Reed JC, Sawyers CL. Neshat MS, et al. Mol Cell Biol. 2000 Feb;20(4):1179-86. doi: 10.1128/MCB.20.4.1179-1186.2000. Mol Cell Biol. 2000. PMID: 10648603 Free PMC article.
Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation.
Gishizky ML, Cortez D, Pendergast AM. Gishizky ML, et al. Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):10889-93. doi: 10.1073/pnas.92.24.10889. Proc Natl Acad Sci U S A. 1995. PMID: 7479904 Free PMC article.
BCR/ABL induces multiple abnormalities of cytoskeletal function.
Salgia R, Li JL, Ewaniuk DS, Pear W, Pisick E, Burky SA, Ernst T, Sattler M, Chen LB, Griffin JD. Salgia R, et al. J Clin Invest. 1997 Jul 1;100(1):46-57. doi: 10.1172/JCI119520. J Clin Invest. 1997. PMID: 9202056 Free PMC article.
Increased sensitivity to apoptotic stimuli in c-abl-deficient progenitor B-cell lines.
Dorsch M, Goff SP. Dorsch M, et al. Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13131-6. doi: 10.1073/pnas.93.23.13131. Proc Natl Acad Sci U S A. 1996. PMID: 8917556 Free PMC article.
Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B, Skorski T. Nieborowska-Skorska M, et al. J Exp Med. 1999 Apr 19;189(8):1229-42. doi: 10.1084/jem.189.8.1229. J Exp Med. 1999. PMID: 10209040 Free PMC article.

References

1. J Natl Cancer Inst. 1973 Mar;50(3):603-23 - PubMed
1. Leukemia. 1994 Apr;8(4):620-30 - PubMed
1. Blood. 1974 Jun;43(6):847-59 - PubMed
1. Br J Cancer. 1974 Jul;30(1):1-12 - PubMed
1. Mol Cell Biol. 1983 May;3(5):773-9 - PubMed

A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells - PubMed (original) (raw)